PB1762: PONATINIB VERSUS IMATINIB WITH REDUCED‐INTENSITY CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME–POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): PHALLCON STUDY

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; no. Suppl; pp. 1643 - 1644
Main Authors Jabbour, E., Martinelli, G., Vignetti, M., Kantarjian, H., Gomez‐Almaguer, D., Minami, Y., Dombret, H., Hennessy, M., Vorog, A., Wang, B., Ribera, J.‐M.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 23.06.2022
Wiley
Subjects
Publication Only
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000849904.09812.c6